Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)

NCT01065766 · clinicaltrials.gov ↗

COMPLETED

Status

4065

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin/metformin

Sponsor

Merck Sharp & Dohme LLC